Respiratory Viral Control Products 

IVD diagnostic quality controls for respiratory pathogens.

Your Trusted Source for Respiratory Viral Molecular Controls

Microbix’s easy-to-use liquid and swab formats make our respiratory molecular IVD controls a confident choice for researchers, diagnostics and healthcare professionals. 

The respiratory viral control panel includes a complete SARS-CoV-2 panel including SARS-CoV-2 positive, SARS-CoV-2 variants (B.1.1.7, B.1.351, P.1, B.1.617, B.1.1.529), and other influenza viruses and respiratory infections products including:

  • Influenza A

  • Influenza B

  • Respiratory NAAT 

  • Low and ultra-low levels of Flu A and B, RSV, respiratory NAAT

  • Low and ultra-low levels of RSV, adenovirus, parainfluenza 3, Group A streptococcus (M1 and M2) and, various multiplex controls. 

Proudly Supporting Over 100+ Customers with Leading  Diagnostic Solutions 

Microbix approached us before the pandemic started, and the relationship developed so easily and quickly that we formalized our collaboration in 2020. Along with their excellent technical capabilities, they have successfully developed relationships with many diagnostics manufacturers around the world. We are pleased that our FLOQSwabs® are their exclusive choice for their growing line of swab formatted QAPs™”

Gaetano Natale, Chief Commercial Officer.

Setting the Gold Standard for Infectious Disease Diagnostic StandardsEnhancing Diagnostics Precision

Microbix’s Respiratory External Quality controls are the only controls to be desiccated on Copan’s FLOQSwab® for use in diagnostic labs, EQA providers, diagnostic manufacturers, and more. These swabs are room-temperature stable and are easier to ship with a wide storage range of 2℃-30℃.

Global Manufacturing Excellence

Manufactured under the strictest requirements of ISO 13485:2016, Microbix IVD quality controls are CE marked, registered with the U.S. FDA and Australian TGA and Health Canada establishment licensed.

Advanced Diagnostic Solutions

Our respiratory viral molecular controls have unique product offerings including a SARS-CoV-2 complete panel and multiple analyte products. 

Download Our Full Product Catalogue 

News & Insights from Our Diagnostics Experts

  • Microbix’s Clot-Buster Drug Project Advances

    Sequel Pharma Executes Agreement with CDMO for Drug Substance Production MISSISSAUGA, CANADA, March 14, 2024 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that its funding and commercialization partner, Sequel Pharma, LLC (“Sequel”), has executed, with support from Microbix, an agreement with a leading international contract…

Speak to a Respiratory Viral Antigen Controls Customer Service Representative

Let our knowledgeable experts help you secure your respiratory viral panel controls today.







    Frequently Asked Questions

    What respiratory viruses are covered by your antigen controls?

    This panel includes a complete SARS-CoV-2 panel including SARS-CoV-2 positive, SARS-CoV-2 Variants (B.1.1.7, B.1.351, P.1, B.1.617, B.1.1.529), and Other Respiratory products including Influenza A, Influenza B, Respiratory NAAT Low and Ultra low levels of Flu A and B, RSV, Respiratory NAAT Low and Ultra low levels of RSV, Adenovirus, Parainfluenza 3, Group A Streptococcus (M1 and M2) and, various Multpliex controls. 

    Are these controls suitable for use in clinical diagnostic tests for respiratory viruses?

    Yes. 

    Our IVD brand (REDx™) products are unassayed controls that can be used for ongoing QC, benchmarking laboratory testing performance, operatory training and competency, and end-to-end workflow evaluation. 


    Our Research Use Only (RUO) brand (PROCEEDx™) products are used for assay verification/validation, training, and R&D purposes. 

    Are your controls compatible with commonly used diagnostic methods, such as PCR or rapid tests?

    Yes. All of our QAP products are designed to be commutable (i.e., they are compatible with both molecular and immunodiagnostic). However, in certain cases, our products are only designed to be compatible with molecular diagnostics based on the market’s needs.

    What is the shelf life of your respiratory viral antigen controls?

    Depending on the products, 24 weeks to two years from the manufacturing date when stored at 2℃-30℃.

    Single Analyte Products
    Product NameREDx™ (IVD)
    Catalogue Number
    PROCEEDx™ (RUO)
    Catalogue Number
    Download Brochure
    Adenovirus PositiveComing soonVP-15-01
    Parainfluenza 3 PositiveComing soonVP-10-M1
    RSV PositiveRED-07-01VP-07-01
    RSV Positive SwabRED-S-07-01VP-S-07-01
    Respiratory NAAT RSV Positive SwabComing soonComing soon
    Influenza A PositiveRED-13-01VP-13-01
    Influenza A Positive SwabRED-S-13-01VP-S-13-01
    Respiratory NAAT Influenza A Positive SwabComing soonComing soon
    Influenza B PositiveRED-14-01VP-14-01
    Influenza B Positive SwabRED-S-14-01VP-S-14-01
    Respiratory NAAT Influenza B Positive SwabComing soonComing soon
    Multiple Analyte Products
    Product NameREDx™ (IVD)
    Catalogue Number
    PROCEEDx™ (RUO)
    Catalogue Number
    Download Brochure
    Influenza A + Influenza B Positive RED-13-02 VP-13-02
    Influenza A + RSV Positive Coming soon VP-13-03
    Influenza A + Rotavirus Positive Coming soon VP-13-05
    Influenza B + RSV Positive Coming soon VP-14-02
    Adenovirus + RSV Positive Coming soon VP-07-02
    Influenza B + Adenovirus Positive Coming soon VP-14-03
    RSV + Rotavirus Positive Coming soon VP-07-03
    Influenza B + Rotavirus Positive Coming soon VP-14-04
    Adenovirus + Rotavirus Positive Coming soon VP-15-02
    Influenza A + Adenovirus Positive Coming soon VP-13-04
    SARS-CoV-2/FluA&B/RSV Positive Swab RED-S-19-M1VP-S-19-M1
        
    Negative Analyte Products
    Product NameREDx™ (IVD)
    Catalogue Number
    PROCEEDx™ (RUO)
    Catalogue Number
     Download Brochure
    SARS-CoV-2 Negative Swab (REDxFLOQ®)
    NAAT Negative Swab (PTDx & PROCEEDxFLOQ®)
    RED-S-99-01VP-S-99-01 
    Respiratory NegativeComing soonVP-99-01